FibroGen Stock Bearish By 30% In The Last 21 Sessions

FibroGen Inc., whose shares are traded on San Francisco’s Biopharmaceutical Exchange, recently experienced a significant market event. The shares observed a steep 30.63% decline over 21 sessions, closing at $0.88 at 15:07 EST on Wednesday. Remarkably, this decline mirrored a decrease in the NASDAQ Composite index by 0.311%. FibroGen’s Product Portfolio Having carved a niche…

Read More

IShares Short-Term Already 5% Down, Almost Two Hours Before The NASDAQ Open

(VIANEWS) – The NASDAQ opens in less than two hours and iShares Short-Term‘s pre-market value is already 5.92% down. The last session, NASDAQ finished with iShares Short-Term (IGSB) falling 0.06% to $50.17. NASDAQ rose 0.61% to $14,144.56, after two successive sessions in a row of gains, on what was a somewhat positive trend exchanging session….

Read More